Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13398798 | 0.97 | ALDH1A1 (0.58) | ALDH1A1EPHX1TSHRSIGMAR1TDP1 | |
| SCHEMBL12376981 | 0.97 | ALDH1A1 (0.58) | ALDH1A1EPHX1TSHRSIGMAR1TDP1 | |
| SCHEMBL17145417 | 0.94 | — | — | |
| SCHEMBL24622845 | 0.90 | ALDH1A1 (0.50) | ALDH1A1EPHX1TSHRSIGMAR1CYP1A2 | |
| SCHEMBL23135362 | 0.87 | ALDH1A1 (0.54) | ALDH1A1EPHX1SIGMAR1CYP1A2 | |
| SCHEMBL28703085 | 0.87 | ALDH1A1 (0.79) | ALDH1A1EPHX1TDP1MEN1KMT2A | |
| SCHEMBL7517505 | 0.85 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRTDP1MEN1 | |
| SCHEMBL33715 | 0.85 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRTDP1MEN1 | |
| SCHEMBL5340594 | 0.85 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRTDP1MEN1 | |
| SCHEMBL7511568 | 0.85 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| US-9921477-B2 | Photoactivable nitrogen bases | BASE SE (DE) | 2018-03-20 | — | — | US | disclosed |
| US-8785592-B2 | Preparation of poly(alkylene carbonate) containing cross-linked high molecular weight chains | SK INNOVATION CO., LTD. (KR) | 2014-07-22 | — | — | US | disclosed |
| US-20120065360-A1 | PREPARATION OF POLY(ALKYLENE CARBONATE) CONTAINING CROSS-LINKED HIGH MOLECULAR WEIGHT CHAINS | SK INNOVATION CO., LTD. (KR) | 2012-03-15 | — | — | US | disclosed |
| US-20100105794-A1 | PHOTOACTIVABLE NITROGEN BASES | CIBA CORPORATION (US) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | CBR1, NR0B1, NR0B2 | ALDH1A1 1733/4885EPHX1 2569/4885TSHR 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.